Consult with a Board Certified Physician to get prescription weight loss medication online

Compound
Semaglutide

Introductory first month at $199. $299 for subsequest months. Lose up to 16.9% body weight. Same ingredient as Ozempic and Wegovy.
Includes supplies and shipping.
‍
Includes supplies and shipping.
Get Started

Compound
Tirzepatide

$395 per month includes shipping. Lose up to 22.5% body weight loss. Same ingredient as Monjaro.

Includes supplies and shipping.
Get Started

Brand
Wegovy

$90 for initial consult
$75 for refill consults. You pay for medication at your pharmacy of choice.

Cost of medication may be covered by your insurnace.
Get Started

Brand
Mounjarao

$90 for initial consult
$75 for refill consults. You pay for medication at your pharmacy of choice.

Cost of medication may be covered by your insurnace.
Get Started

16-20 %

Our weight loss program helps you lose up to 16-20% of body weight by utilizing a GLP-1 class medication, together with a reduced calorie diet and exercise.
‍
Glucagon-like peptide-1 (GLP-1) agonists (also known as GLP-1 receptor agonists, incretin mimetics, or GLP-1 analogs) represent a class of medications used to treat type 2 diabetes mellitus and, in some cases, obesity.

YOUR PATHWAY TO BETTER HEALTH

GETTING STARTED
  • Meet with our medical provider for a comprehensive evaluation and prescription if eligible.
    ‍
DURING THE PROGRAM
  • You will have monthly visits with our provider for refills and to ensure the medication continues to be safe and effective for you. To qualify for the first refill you will need to do a lab test to ensure this medication is safe for you. You will receive a Quest Diagnostic Lab order with your second visit.
    ‍
  • It is important to combine a healthy diet and exercise at least 20 mins 3 times a week with weight loss medications.
TRANSPARENT  COST
  • We do not require a subscription. You can stop anytime you feel you have achieved your weight loss goal.

    If you select brand medication we will help you with prior-authorization and coupons that can reduce the high cost of brand drugs.

MEDICATION OPTIONS

PLEASE REVIEW THE MEDICATION OPTIONS BELOW. OUR PROVIDER WILL DISCUSS THESE OPTIONS FOR SAFETY, EFFICACY AND COST.

Compound Semaglutide
Compound Tirzepatide
Wegovy
Mounjaro

Compound Semaglutide

The defining characteristic of compounded semaglutide lies in its fusion of traditional semaglutide with other body-safe vitamins, such as B12. Semaglutide, a GLP1 receptor agonist, was initially engineered to combat diabetes by regulating blood glucose levels through the stimulation of insulin release.

Compounded semaglutide is not currently offered in Alabama, Alaska, Arkansas, California, Hawaii, Louisiana, Mississippi, Virginia, and the District of Columbia.

Expected weight loss is 16.9% of body weight.

Compound Tirzepatide

Tirzepatide is an antidiabetic medication used for the treatment of type 2 diabetes and for weight loss.Tirzepatide is administered via subcutaneous injections (under the skin). It is sold under the brand names Mounjaro for diabetes treatment, and Zepbound for weight loss. Tirzepatide is a gastric inhibitory polypeptide receptor and glucagon-like peptide-1 agonist. The most common side effects include nausea, vomiting, diarrhea, decreased appetite, constipation, upper abdominal discomfort, and abdominal pain.

Expected weight loss is 22.5% of body weight.

Wegovy®‍

WEGOVY® (semaglutide) injection 2.4 mg is an injectable prescription medicine that may help adults with obesity (BMI ≥30 for adults, or some adults with excess weight (BMI ≥27) (overweight) who also have weight-related medical problems to help them lose weight and keep it off. Wegovy® should be used with a reduced calorie meal plan and increased physical activity Wegovy® contains semaglutide and should not be used with other semaglutide-containing products or other GLP-1 receptor agonist medicine. It is not known if Wegovy® is safe and effective when taken with other prescription, over-the-counter, or herbal weight loss products. It is not known if Wegovy® can be used safely in people with a history of pancreatitis.

Expected weight loss is 16.9% of body weight.
‍

Mounjaro® (Tirzepatide)

Tirzepatide, sold under the brand name Mounjaro among others, is an antidiabetic medication used for the treatment of type 2 diabetes and for weight loss. Tirzepatide is administered through subcutaneous injection.

Expected weight loss is 22.5% of body weight.

‍

Reproductive Considerations

  • Women who plan to become pregnant should not take weight loss medications.
  • Taking weight loss medications at the time of conception can cause harm to the developing child.
  • Weight loss medications should be discontinued at lease 2 months prior to attempting to become pregnant.
  • Contraception should be used for the entire duration of therapy and continued for two months once therapy ends.
  • We recommend pregnancy testing prior to beginning therapy with weight loss medications.
  • Women of child bearing age should monitor their menstrual cycles closely and perform regular pregnancy testing with your primary care provider or gynecologist.

AM I A CANDIDATE?

GenieMD is HIPAA Compliant
GenieMD is Legitscript Certified
GenieMD is the recipient of 2021 Frost & Sullivan Best Practices Award
Copyright © 2024 GenieMD, Inc.
Privacy Policy